Lindsey Bohl is a Partner in Simpson Thacher’s Washington, D.C. office. She advises on matters involving all aspects of antitrust and competition law, including merger reviews, government antitrust investigations and antitrust litigation. Her practice focuses on counseling clients considering M&A transactions across a wide range of industries, including healthcare, retail, consumer products, technology and medical devices and pharmaceutical products.
Before rejoining Simpson Thacher, where she began her career as an associate, Lindsey was a staff attorney in the FTC’s Mergers IV Division, where she led significant healthcare and retail transaction investigations and litigated merger challenges, including the FTC’s successful lawsuit challenging Hackensack Meridian Health’s acquisition of Englewood Health in New Jersey. She earned her J.D., cum laude, from Georgetown University Law Center and her B.A., magna cum laude, from Vanderbilt University. She is admitted to practice in Washington, D.C. and New York.